Literature DB >> 19693467

Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia.

Li Pan1, Jian-Hua Fu, Xin-Dong Xue, Wei Xu, Ping Zhou, Bing Wei.   

Abstract

BACKGROUND: Oxidative stress plays an important role in the pathogenesis of bronchopulmonary dysplasia (BPD). Melatonin (MT) has direct and indirect free radical detoxifying activity. The present study was to investigate whether treatment with MT would attenuate hyperoxia-induced lung injury and the effect of MT on imbalance of oxidants/antioxidants in the lung of neonatal rats.
METHODS: BPD was induced by exposure to hyperoxia in neonatal rats (n=90). The rats were divided randomly into three groups (n=30 each): air-exposed control group, hyperoxia-exposed group, and hyperoxia-exposed MT-treated group. Lung specimens were obtained respectively on day 3, day 7, and day 14 after exposure (n=10 each). Activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT), and levels of myeloperoxidase (MPO), nitrite/nitrate, and malondialdehyde (MDA) were assayed. Histopathologic changes were observed in the tissues stained with hematoxylin and eosin and Masson's trichrome stain.
RESULTS: Increased levels of MPO, nitrite/nitrate, and MDA in the hyperoxia-exposed rats were significantly reduced by MT (P<0.05). Activities of GSH-Px, SOD, and CAT which did not change after exposure to hyperoxia were increased by MT (P<0.05). Furthermore, BPD associated histopathological alterations such as reduced total number of alveoli and interstitial fibrosis were obviously abated in the MT-treated group.
CONCLUSIONS: MT can reverse oxidants/antioxidants imbalance in damaged lung tissue and thus exert a beneficial effect on hyperoxia-induced lung disease in neonatal rats. With regard to humans, there may be a protective effect of MT on BPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693467     DOI: 10.1007/s12519-009-0041-2

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  26 in total

1.  Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment.

Authors:  Eloisa Gitto; Russel J Reiter; Giuseppe Sabatino; Giuseppe Buonocore; Carmelo Romeo; Placido Gitto; Concetta Buggé; Giuseppe Trimarchi; Ignazio Barberi
Journal:  J Pineal Res       Date:  2005-10       Impact factor: 13.007

Review 2.  Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia.

Authors:  Linda J Van Marter
Journal:  Biol Neonate       Date:  2006-06-01

3.  Melatonin regulation of antioxidant enzyme gene expression.

Authors:  J C Mayo; R M Sainz; I Antoli; F Herrera; V Martin; C Rodriguez
Journal:  Cell Mol Life Sci       Date:  2002-10       Impact factor: 9.261

4.  Effectiveness of a treatment based on melatonin in five patients with systemic sclerosis.

Authors:  Mauro Todisco
Journal:  Am J Ther       Date:  2006 Jan-Feb       Impact factor: 2.688

5.  Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats.

Authors:  K A Veness-Meehan; F G Bottone; A D Stiles
Journal:  Pediatr Res       Date:  2000-10       Impact factor: 3.756

6.  Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia.

Authors:  Riitta Kaarteenaho-Wiik; Vuokko L Kinnula
Journal:  J Histochem Cytochem       Date:  2004-09       Impact factor: 2.479

Review 7.  Role of oxidative stress as physiopathologic factor in the preterm infant.

Authors:  C Dani; A Cecchi; G Bertini
Journal:  Minerva Pediatr       Date:  2004-08       Impact factor: 1.312

Review 8.  Melatonin: detoxification of oxygen and nitrogen-based toxic reactants.

Authors:  Russel J Reiter; Dun-Xian Tan; Lucien C Manchester; Silvia Lopez-Burillo; Rosa M Sainz; Juan C Mayo
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

9.  Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice.

Authors:  B Al Qadi-Nassar; F Bichon-Laurent; K Portet; P Tramini; B Arnoux; A Michel
Journal:  Fundam Clin Pharmacol       Date:  2007-12       Impact factor: 2.748

Review 10.  Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy.

Authors:  Tiina M Asikainen; Carl W White
Journal:  Antioxid Redox Signal       Date:  2004-02       Impact factor: 8.401

View more
  10 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

Review 3.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  Future applications of antioxidants in premature infants.

Authors:  Jennifer W Lee; Jonathan M Davis
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

Review 5.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 6.  Effects of Antioxidants in Human Milk on Bronchopulmonary Dysplasia Prevention and Treatment: A Review.

Authors:  Xianpeng Yang; Shanyu Jiang; Xianhui Deng; Zichen Luo; Ailing Chen; Renqiang Yu
Journal:  Front Nutr       Date:  2022-07-18

7.  Urinary biomarkers for the early prediction of bronchopulmonary dysplasia in preterm infants: A pilot study.

Authors:  Xuewei Cui; Jianhua Fu
Journal:  Front Pediatr       Date:  2022-08-11       Impact factor: 3.569

Review 8.  Antioxidant strategies and respiratory disease of the preterm newborn: an update.

Authors:  Chiara Poggi; Carlo Dani
Journal:  Oxid Med Cell Longev       Date:  2014-04-07       Impact factor: 6.543

Review 9.  Protective role of melatonin in neonatal diseases.

Authors:  Eloisa Gitto; Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Ignazio Barberi; Carmelo Salpietro; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2013-11-19       Impact factor: 6.543

Review 10.  Supplemental Oxygen in the Newborn: Historical Perspective and Current Trends.

Authors:  Maxwell Mathias; Jill Chang; Marta Perez; Ola Saugstad
Journal:  Antioxidants (Basel)       Date:  2021-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.